AbstractHuman embryonic stem cells (hESCs) were used as a model system of human pancreas development to study characteristics of the polyhormonal cells that arise during fetal pancreas development. HESCs were differentiated into fetal-like pancreatic cells in vitro using a 33-day, 7-stage protocol. Cultures were ~90–95% PDX1-positive by day (d) 11 and 70–75% NKX6.1-positive by d17. Polyhormonal cells were scattered at d17, but developed into islet-like clusters that expressed key transcription factors by d33. Human C-peptide and glucagon secretion were first detected at d17 and increased thereafter in parallel with INS and GCG transcript levels. HESC-derived cells were responsive to KCl and arginine, but not glucose in perifusion studies. C...
AbstractThere are several challenges to successful implementation of a cell therapy for insulin depe...
Cell transplantation of pancreatic islets has been proven to be an effective long-term treatment fo...
SummaryHuman pluripotent stem cells (hPSCs) represent a renewable source of pancreatic beta cells fo...
AbstractHuman embryonic stem cells (hESCs) were used as a model system of human pancreas development...
<div><p>Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage di...
Pancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, functional ...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differenti...
AbstractEmbryonic pancreatic bud cells, the earliest pancreas-committed cells, generated from human ...
Efficiently obtaining functional pancreatic islet cells derived from human embryonic stem (hES) cell...
The murine embryonic stem (ES) cell line, ES-D3 was used in this project as a model for (a) investig...
BACKGROUND:Human pancreatic islet transplantation is a prospective curative treatment for diabetes. ...
Introduction: With the shortage of donor organs for islet transplantation, insulin-producing cells h...
Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differenti...
Transplantation of pancreatic islet cells derived from human pluripotent stem cells is a promising t...
AbstractThere are several challenges to successful implementation of a cell therapy for insulin depe...
Cell transplantation of pancreatic islets has been proven to be an effective long-term treatment fo...
SummaryHuman pluripotent stem cells (hPSCs) represent a renewable source of pancreatic beta cells fo...
AbstractHuman embryonic stem cells (hESCs) were used as a model system of human pancreas development...
<div><p>Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage di...
Pancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, functional ...
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endoc...
Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differenti...
AbstractEmbryonic pancreatic bud cells, the earliest pancreas-committed cells, generated from human ...
Efficiently obtaining functional pancreatic islet cells derived from human embryonic stem (hES) cell...
The murine embryonic stem (ES) cell line, ES-D3 was used in this project as a model for (a) investig...
BACKGROUND:Human pancreatic islet transplantation is a prospective curative treatment for diabetes. ...
Introduction: With the shortage of donor organs for islet transplantation, insulin-producing cells h...
Human embryonic stem cells (hESCs) are pluripotent and capable of undergoing multilineage differenti...
Transplantation of pancreatic islet cells derived from human pluripotent stem cells is a promising t...
AbstractThere are several challenges to successful implementation of a cell therapy for insulin depe...
Cell transplantation of pancreatic islets has been proven to be an effective long-term treatment fo...
SummaryHuman pluripotent stem cells (hPSCs) represent a renewable source of pancreatic beta cells fo...